<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: This study assessed <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:chebi fb="15" ids="39026">LDL</z:chebi> from <z:mp ids='MP_0001261'>obese</z:mp> patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and compared it with that in <z:chebi fb="15" ids="39026">LDL</z:chebi> from type 2 diabetic patients or control volunteers </plain></SENT>
<SENT sid="1" pm="."><plain>It also determined the effect on platelets of <z:chebi fb="15" ids="39026">LDL</z:chebi> from the three groups </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The profiles of <z:chebi fb="23" ids="18059">lipids</z:chebi>, fatty acids and fatty acid oxidation products were determined in <z:chebi fb="15" ids="39026">LDL</z:chebi> isolated from plasma of patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and volunteers (n = 10 per group) </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of <z:chebi fb="15" ids="39026">LDL</z:chebi> from the participant groups on the platelet <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> signalling cascade and aggregation were investigated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Compared with <z:chebi fb="15" ids="39026">LDL</z:chebi> from control volunteers, <z:chebi fb="15" ids="39026">LDL</z:chebi> from <z:mp ids='MP_0001261'>obese</z:mp> <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 diabetic patients had lower cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi>, higher triacylglycerol and lower <z:chebi fb="0" ids="16000,23981">ethanolamine</z:chebi> plasmalogen levels </plain></SENT>
<SENT sid="5" pm="."><plain>Proportions of <z:chebi fb="0" ids="17351">linoleic acid</z:chebi> were decreased in <z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi> and cholesteryl <z:chebi fb="21" ids="35701">esters</z:chebi> in <z:chebi fb="15" ids="39026">LDL</z:chebi> from both patient groups </plain></SENT>
<SENT sid="6" pm="."><plain>Among the markers of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, oxidation products of <z:chebi fb="0" ids="17351">linoleic acid</z:chebi> (hydroxy-<z:chebi fb="0" ids="25627">octadecadienoic acids</z:chebi>) and malondialdehyde were increased by 59% and twofold, respectively in <z:chebi fb="15" ids="39026">LDL</z:chebi> from <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 diabetic patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="15" ids="39026">LDL</z:chebi> from <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 diabetic patients were equally potent in activating the platelet <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> signalling cascade through increased phosphorylation of p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase and cytosolic phospholipase A(2), and through increased <z:chebi fb="0" ids="26995">thromboxane</z:chebi> B(2) formation </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="15" ids="39026">LDL</z:chebi> from patients with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> potentiated platelet aggregation by threefold and 3.5-fold respectively, whereas control <z:chebi fb="15" ids="39026">LDL</z:chebi> had no activating effects on platelets </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> in <z:mp ids='MP_0001261'>obese</z:mp> patients, without or with <z:mp ids='MP_0002055'>diabetes</z:mp>, is associated with increased <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:chebi fb="15" ids="39026">LDL</z:chebi>, which triggers platelet activation </plain></SENT>
</text></document>